课题基金 / 基金详情

APOC - multiplexed acoustic point of care diagnostic system for STIs

APOC - multiplexed acoustic point of care diagnostic system for STIs
APOC - STI 多路声学护理点诊断系统
批准号:
102851
负责人:
金额:
$96.31万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
SAW-Dx Ltd是一家新兴的床旁(POC)诊断设备设计和制造公司,使用围绕超声技术的专有创新。该项目将进一步推进SAW-Dx的雄心,以满足对性传播感染POC诊断测试日益增长的需求。目前,疾病控制中心估计,仅在美国,每年就有超过2000万例新的性传播感染。我们建议,我们的声流技术将成为STI快速核酸检测(NAT)的基础。一旦得到证实,该技术也有可能在未来进入其他POC诊断市场(包括结核病和HCV)。该项目将构建并验证一个原型(便携式读取器和一次性检测盒),以在样本进入检测设备(或“芯片”)后30分钟内驱动诊断检测得出结果,无需用户干预。这将使患者能够立即治疗(目前患者必须在几天后返回以获得结果-许多人没有)。我们未来的目标是看到我们的平台被采用到许多不同的医疗保健市场-因为它的简单性有助于跨平台兼容性。
英文摘要
SAW-Dx Ltd is an emerging point-of-care (POC) diagnostic device design and manufacturing company, using proprietary innovations around ultrasonic technologies. This project will further the ambition of SAW-Dx to meet the growing demand for POC diagnostic tests for sexually transmitted infections. Currently the Center for Disease Control estimate >20M new STIs every year, in the US alone. We propose that our Acoustic-Flow technology will form the basis of a rapid nucleic acid test (NAT) for STIs. Once demonstrated, the technology also has potential to reach into other POC diagnostics markets (including e.g. tuberculosis and HCV) in the future. This project will build and validate a prototype (portable reader and disposable cartridge) to drive a diagnostic test to a result, with no user intervention after the sample enters the test device (or “chip”), within 30 min. This will enable the immediate treatment of the patient (currently patients must return to obtain their results after several days – many do not). Our future ambitions will see our platform being adopted into a number of different healthcare markets - as its simplicity lends itself to cross-platform compatibility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金